Several nonmalignant processes, including benign prostatic hyperplasia (BPH) and prostatitis, which occur in many men as they age, frequently lead to serum PSA increment, limiting the specificity of PSA for cancer detection [3]. The gene discussed is KLK3; the disease is benign prostatic hyperplasia.